NDC 0409-1144-01 - Verapamil Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1144
- Requested NDC
- 0409-1144-01
- Package NDCs from labels
- 0409-1144-62, 0409-1144-02, 0409-1144-65, 0409-1144-05, 0409-1144-11, 0409-1144-10, 0409-1144-01
- Manufacturer
- Hospira, Inc.
- Effective date
- 2026-07-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Verapamil Hydrochloride Injection, USP | Hospira, Inc. | 2026-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Verapamil Hydrochloride Injection, USP | Hospira, Inc. | Pfizer Healthcare India Private Limited | Nitto Avecia Pharma Services, Inc. | 2026-04-29 | HUMAN PRESCRIPTION DRUG LABEL |
| VERAPAMIL HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-19 | HUMAN PRESCRIPTION DRUG LABEL |
| VERAPAMIL HCI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Verapamil Hydrochloride - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2019-12-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Verapamil Hydrochloride - Cardinal Health | Cardinal Health | 2019-09-13 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1144-02 | Verapamil Hydrochloride | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 24 | |
| 0409-1144-05 | Verapamil Hydrochloride | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 24 | |
| 0409-1144-62 | Verapamil Hydrochloride | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 24 | |
| 0409-1144-65 | Verapamil Hydrochloride | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 24 | |
| 0409-1144-10 | Verapamil Hydrochloride | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 14 | |
| 0409-1144-11 | Verapamil Hydrochloride | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 14 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0409-1144 | VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 22 | Current NDC, Legacy NDC, 4 package rows | 20241109_1c993365-1b62-4524-e781-d307f28f63bc.zip |
| 0409-1144 | VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20241024_70057a53-ca29-4848-ab3d-5e691e2a14a3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-1144-01 | ML - Milliliter | 0409-1144 | 1c0cbad9-d3a6-4e81-a12d-bc7278813752 | 1 | 2012-07-24 |
| 0409-1144-02 | ML - Milliliter | 0409-1144 | 2a1dfbca-a12c-41cc-af25-c1d6dd5ebcd6 | 1 | 2012-07-24 |
| 0409-1144-05 | ML - Milliliter | 0409-1144 | 067508cf-4ac4-4905-9b50-eac564de3b98 | 1 | 2012-07-24 |
| 0409-1144-10 | ML - Milliliter | 0409-1144 | 69396de1-9dc4-4aa6-9115-796721a02be3 | 1 | 2018-07-03 |
| 0409-1144-11 | ML - Milliliter | 0409-1144 | 0547e790-5b24-4ff0-9cfd-aa764e9c15c1 | 1 | 2018-07-03 |
| 0409-1144-62 | ML - Milliliter | 0409-1144 | 499e8c34-0c1b-4fb9-9ebc-bf0c7900ee9d | 1 | 2019-07-02 |
| 0409-1144-65 | ML - Milliliter | 0409-1144 | 04b1829a-5f8e-4594-afae-8a316138740a | 1 | 2019-07-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ReHydration | ADENOSINUM CYCLOPHOSPHORICUM, COFFEA CRUDA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, NATRUM MURIATICUM, SARSAPARILLA, SILICEA, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE) | Energetix Corp | 9883c502-9782-451e-9eec-c54d7b054f31 | 2017-01-31 | Warnings | 451W47IQ8X |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | EXELA PHARMA SCIENCES, LLC | 3318e357-0660-44f4-8170-91a51bd762fb | 2017-01-23 | Warnings, Adverse reactions | 1665057 V3888OEY5R |
| Tox-Chord | ALFALFA, ALUMINA, BENZOICUM ACIDUM, CARBONEUM, CETRARIA ISLANDICA, FOLLICULINUM, FUCUS VESICULOSUS, FUMARICUM ACIDUM, HEPAR SUIS, KALI CARBONICUM, KREOSOTUM, NATRUM MURIATICUM, PARAFFINUM, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, PIX LIQUIDA, PLANTAGO MAJOR, PLUMBUM METALLICUM, PULSATILLA (VULGARIS), RADIUM BROMATUM, RESORCINUM, SALOL, SILICEA, SYMPHYTUM OFFICINALE, TABACUM, TEREBINTHINA, THYROIDINUM (BOVINE), TRITICUM REPENS, ZINCUM OXYDATUM | Energetix Corp | 6b0d1628-b20d-426e-9c84-5cceadca3f45 | 2016-11-11 | Warnings | 451W47IQ8X |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | 2a96096d-43cc-49b7-af53-b53c17f41001 | 2014-07-25 | Warnings, Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | b3b4b176-41f0-4ca8-90d4-3fba5707564a | 2014-02-21 | 451W47IQ8X | |
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | 451W47IQ8X | |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, | Baxter Healthcare Corporation | e1953d54-818d-46a6-8532-518ebae6d84e | 2012-06-13 | 451W47IQ8X | |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.